Prathyusha Durabaibu
Vermögen: 614 639 $ am 31.05.2026
Vermögen: 614 639 $ am 31.05.2026
Ms. Prathyusha Durabaibu is an Independent Director at Organogenesis Holdings, Inc. She is on the Board of Directors at Organogenesis Holdings, Inc. Ms. Durabaibu was previously employed as a Principal Financial Officer by Sangamo Therapeutics, Inc. and a Controller by Pacific Biosciences of California, Inc. She received her undergraduate degree from Oxford Brookes University and an MBA from San Jose State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 198’219 ( 0.15% ) | 509 423 $ | 31.05.2026 | |
| 22.01.2026 | 482’645 ( 0.12% ) | 105 217 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Direktor/Vorstandsmitglied | 19.11.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Finanzdirektor/CFO | 03.02.2026 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Comptroller/Controller/Auditor | 01.03.2019 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Oxford Brookes University
Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen